• Citer

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

par Crook, Derrick W;Walker, A Sarah;Kean, Yin;Weiss, Karl;Cornely, Oliver A;Miller, Mark A;Esposito, Roberto;Louie, Thomas J;Stoesser, Nicole E;Young, Bernadette C;Angus, Brian J;Gorbach, Sherwood L;Peto, Timothy E A;Jacobs, Frédérique
Référence Clinical infectious diseases, 55 Suppl 2, page (S93-103)
Publication Publié, 2012-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.
Auteur:	Crook, Derrick W; Walker, A Sarah; Kean, Yin; Weiss, Karl; Cornely, Oliver A; Miller, Mark A; Esposito, Roberto; Louie, Thomas J; Stoesser, Nicole E; Young, Bernadette C; Angus, Brian J; Gorbach, Sherwood L; Peto, Timothy E A; Jacobs, Frédérique
Informations sur la publication:	Clinical infectious diseases, 55 Suppl 2, page (S93-103)
Statut de publication:	Publié, 2012-08
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aminoglycosides -- therapeutic use
	Anti-Bacterial Agents -- therapeutic use
	Clostridium Infections -- drug therapy -- microbiology -- mortality
	Clostridium difficile -- pathogenicity
	Diarrhea -- drug therapy -- microbiology
	Eosinophils
	Feces -- microbiology
	Humans
	Intention to Treat Analysis
	Leukocyte Count
	Proportional Hazards Models
	Prospective Studies
	Randomized Controlled Trials as Topic
	Recurrence -- prevention & control
	Risk Factors
	Vancomycin -- therapeutic use
Note revue:	Study 003/004 Teams
Note générale:	Journal Article
	Meta-Analysis
	Multicenter Study
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1058-4838
	info:doi/10.1093/cid/cis499
	info:pii/cis499
	info:pmid/22752871
	PMC3388031